| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-20 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-17 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.29 | 8e-14 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-13 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.42 | 1e-12 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.38 | 1e-11 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |